[1]
Haidar Mohammed Hussein and Ali Abdulhussein Kasim, “Correlation of the Complement Decay Accelerating Factor, Tumour Necrosis Factors-alpha, and Interleukin-1 Beta with the Response to Rituximab in Rheumatoid Arthritis Patients”, Iraqi Journal of Pharmaceutical Sciences , vol. 33, no. (4SI), pp. 222–229, Feb. 2025, doi: 10.31351/vol33iss(4SI)pp222-229.